BioCryst Pharmaceuticals, Inc. (BCRX)

7.52 +0.05 (+0.67%) USD  |  NASDAQ  |  Dec 17, 13:27
More

BioCryst Pharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Astria Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
Viatris, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Novavax, Inc. Upgrade